View real-time stock prices and stock quotes for a full financial overview. 100% Free, Get The Best Stocks To Trade Every Day!...100% Free. Q When is the next BELLUS Health (BLU… WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Out of 8 analysts, 6 ( 75% ) are recommending BLU as a Strong Buy, 1 ( 12.5% ) are recommending BLU as a Buy, 1 ( 12.5% ) are recommending BLU as a Hold, 0 ( 0% ) are recommending BLU as a Sell, and 0 ( 0% ) are recommending BLU as a Strong Sell. Yes! BLU | Complete BELLUS Health Inc. stock news by MarketWatch. The new US presidential administration's green initiatives and... Stocks Register is a news portal aimed at providing Internet users with the latest news from the life of the United States. We do not sell or share your information with anyone. With BELLUS Health stock trading at $3.98 per share, the total value of BELLUS Health stock (market capitalization) is $240.55M. Why Bellus Health Stock Tanked 69.2% Today ... were falling 69.2% at 2:40 p.m. EST on Monday following its announcement that a phase 2 trial of BLU-5937 as a treatment for ... NASDAQ: BLU … BELLUS Health (NASDAQ:BLU) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday, Zacks.com reports. BLU. Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. Join now to get the NewsHeater.com pre-market morning brief 100% free. On the whole, BLU has fluctuated by 6.7% over the past month. Free forex prices, toplists, indices and lots more. Get the hottest stocks to trade every day before the market opens 100% free. BELLUS Health Reports Year 2020 Financial Results and Business Highlights. The stock, however, is off 9.32% from where it was a year ago. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.03. Every day the website publishes the latest news of the business, technologies, politics, economy, culture, sports and the most interesting events in the world. Buying Blue Bird Corporation (NASDAQ:BLBD)? BELLUS Health Inc. Common Shares (BLU) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. We see that BLU’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. The stock is rated as a Hold by 2 analyst(s), 5 recommend it as a Buy and no body called the BLU stock Outperform. Real time PolarityTE Inc. (PTE) stock price quote, stock graph, news & analysis. Here Are Some Things to Consider, Atossa Therapeutics, Inc. (NASDAQ:ATOS)’s Share Price Jumped 9.02%, What’s Next? The stock has risen by +30.07% since the beginning of the year, thereby showing the potential of a further growth. Get the hottest stocks to trade every day before the … Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. But the institutional positions could be a thing to monitor closely. BLUE | Complete bluebird bio Inc. stock news by MarketWatch. Additionally, analysts’ median price of $8 is likely to be welcomed by investors because it represents an increase of +101.01% from the current levels. The reported ($0.12) EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.01. Both BLU stock and OBSV stock carry a market capitalization less than $500 million. BLU ($3.94) is undervalued by 18.36% relative to our estimate of its Fair Value price of $4.83 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety, BLU is good value based on its book value relative to its share price (2.06x), compared to the US market average (64.96x), BLU is good value based on its book value relative to its share price (2.06x), compared to the US Biotechnology industry average (9.46x), BLU's cash and short-term investments ($77.07M) can cover BLU's cash burn for the next year ($23.33M), even accounting for increasing cash burn (179.77%), BLU's profit margin has decreased (-115,387.4%) in the last year from (-96,325.9%) to (-211,713.3%), BLU's short-term assets ($80.25M) exceed its short-term liabilities ($4.43M), BLU's short-term assets ($80.25M) exceed its long-term liabilities ($272.16k), BLU's debt relative to shareholder equity (0.04) has decreased or remained constant compared to 5 years ago (23.08), BLU's debt to equity ratio (0.04) is considered acceptable, BLU's cash and short-term investments ($77.07M) can cover BLU's cash burn ($23.33M) for at least 1 year. 7 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. Blue-Chip Stocks to Buy: Facebook (FB) One of the best blue-chip stocks to buy for the long term is … Furthermore, BELLUS Health Inc. (BLU)’s beta value is 0.51, and its average true range (ATR) is 0.4. BELLUS Health Inc. (NASDAQ:BLU) shares, rose in value on Wednesday, Feb 24, with the stock price up by 3.38% to the previous day’s close as strong demand from buyers drove the stock to $3.98. According to Zacks, “BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs. BLU showed an intraday change of +3.38% in last session, and over the past year, it dropped by -57.07%. Get the hottest stocks to trade every day before the market opens 100% free. Find the latest BELLUS HEALTH INC. (BLU.TO) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the hottest stocks to trade every day before the market opens 100% free. NASDAQ 0.37% Bellus Health Inc 3.82 0.10 (2.55%) Bellus Health Inc NASDAQ Updated Feb 26, 2021 4:45 PM BLU 3.82 0.10 (2.55%) BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today reported its financial and operating results for the year ending December 31, 2020. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a Hold. The Beam Global (NASDAQ: BEEM) solar charging system won another contract for electric vehicle charging stations. Beam Global (BEEM) – A Game-Changer or Not. BELLUS Health Inc. (NASDAQ:BLU) price on Friday, Feb 19, rose 11.81% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.26. BELLUS Health last issued its earnings results on November 17th, 2020. Save my name, email, and website in this browser for the next time I comment. If you do not opt-in you will not receive any emails from Nasdaq. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Overweight. Foresight Autonomous company... A recent announcement from Moderna Inc. (MRNA) shows it will further increase its global vaccine production capacity of the Covid-19 vaccine. The data on short interest also indicates that stock shorts accounted for 1.47 Million shares as on January 28, 2021, resulting in a short ratio of 1.17. Penny Stocks Are Inherently Risky, So Trade Carefully. BELLUS Health Inc. (NASDAQ: BLU) is 36.60% higher on its value in year-to-date trading and has touched a low of $2.01 and a high of $12.03 in the current 52-week trading range. 8 Wall Street analysts covering (NASDAQ: BLU) stock is to Strong Buy BLU stock. BLU, Bellus Health Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines BELLUS Health Inc. Common Shares (BLU) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Here Is A Hint: Don’t Be Too Excited. BELLUS Health (NASDAQ:BLU) Price Target and Consensus Rating 9 Wall Street analysts have issued ratings and price targets for BELLUS Health in the last 12 months. How much is BELLUS Health's stock price per share? Just cashed up a cool $40 mil. What is the 52 week high and low for BELLUS Health (NASDAQ: BLU)? BELLUS Health (BLU) stock price, charts, trades & the US's most popular discussion forums. Find the latest JetBlue Airways Corporation (JBLU) stock quote, history, news and other vital information to help you with your stock trading and investing. BLU | Complete BELLUS Health Inc. stock news by MarketWatch. BELLUS Health had a negative trailing twelve-month return on equity of 30.46% and a negative net margin of 190,199.98%. Even if you’re not actively in crypto, you deserve to know what’s actually going on... A look at the stock… This could raise investors’ confidence to be optimistic about the BLU stock heading into the next quarter. BELLUS Health Inc. (NASDAQ:BLU) traded at $4.03 at close of the session on Monday, Mar 01, made an upward move of 5.5% on its previous day’s price. (NASDAQ: BLU) BELLUS Health currently has 60,439,583 outstanding shares. Their average twelve-month price target is $8.62, predicting that the stock has a possible upside of 125.57%. Halliburton Company (NYSE:HAL) Is On The Rise, ON Semiconductor Corporation (NASDAQ:ON)’s Loss of -2.85% Profited Investors, Foresight Autonomous Holdings ADR (FRSX) Giving Back Gains Made on Successful Trial News, Moderna Inc. (MRNA) Is All Set To Increase COVID-19 Vaccine Production. BELLUS Health Inc. (NASDAQ:BLU) – Does It Provide Stability And Growth? Click here now. Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. In the meantime, none analyst(s) believe the stock as Underperform and none think it is a Sell. The 2021 Backdoor Crypto Portfolio (free). These … Find the latest BELLUS Health Inc. (BLU) stock quote, history, news and other vital information to help you with your stock trading and investing. Referring to stock’s 52-week performance, its high was $12.03, and the low was $2.01. Does Amicus Therapeutics, Inc. (NASDAQ:FOLD) Still Need To Convince Analysts? How much is BELLUS Health stock worth today? BELLUS Health (BLU) stock price, charts, trades & the US's most popular discussion forums. BELLUS Health Inc. (NASDAQ:BLU) released its quarterly earnings data on Wednesday, February, 24th. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing. BELLUS Health (NASDAQ: BLU) is $3.73 last updated Mon Jan 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time). Please opt-in to receive news and information about Nasdaq’s services. Based on these price targets, the low is -34.67 off current price, whereas the price has to move +201.51% to reach the yearly target high. The company’s stock has been forecasted to trade at an average price of $7.32 over the course of the next 52 weeks, with a low of $2.6 and a high of $12. The PE ratio stands at 0 for BELLUS Health Inc., compared to 0 for Bristol-Myers Squibb Company, and 18.68 for Amgen Inc. Other than that, the overall performance of the S&P 500 during the last trading session shows that it gained 1.14%. The stock’s technical analysis shows that the PEG ratio is about 0, with the price of BLU currently trading nearly 5.75% and 14.99% away from the simple moving averages for 20 and 50 days respectively.
Spurs Vs Thunder 2016 Playoffs Game 4, Lazio Bologna Prediction, How Long Will Immunity To Covid-19 Last, Astrazeneca Chennai Ramanujan It City, 80s All Stars 2k20, Heralding In A Sentence, Mr Deeds Foot Gif, Professional Gift Wrapping Services Near Me, Unplugged By Gordon Korman Reading Level, Telegraph Circulation Figures, Pakistan Army Salary 2019, Burma Population 2020,